Breaking News
October 21, 2018 - Income and wealth affect the mental health of Australians, study shows
October 21, 2018 - Patients with hypertension and psoriasis more often require cardiovascular interventions
October 20, 2018 - Leading hip-hop videos depict use of tobacco and marijuana products, study finds
October 20, 2018 - Dose Range of IV Ketamine for Adjunct Tx of Depression Tested
October 20, 2018 - Infants can distinguish between leaders and bullies, study finds
October 20, 2018 - Mad Cow disease found on Aberdeenshire farm
October 20, 2018 - Study identifies factors associated with prescription opioid misuse among students
October 20, 2018 - Scientists uncover key regulator of mTORC1 in cancer growth
October 20, 2018 - Pounds Regained After Weight-Loss Op Can Tell Your Doc a Lot
October 20, 2018 - Sending parents letters to fight childhood obesity doesn’t work
October 20, 2018 - Supervised aerobic exercise can support major depression treatment
October 20, 2018 - Mindfulness-based program effective for reducing stress in infertile women
October 20, 2018 - Molecule capable of halting and reverting neurodegeneration caused by Parkinson’s disease identified
October 20, 2018 - Midazolam-mediated alterations of PER2 expression may have functional consequences during myocardial ischemia
October 20, 2018 - Sweat bees are ideal for studying the genes underlying social behavior
October 20, 2018 - Weight loss success associated with brain areas involved in self-control
October 20, 2018 - KHN’s ‘What the Health?’ Republicans’ preexisting political problem
October 20, 2018 - Research provides a more complete picture of suffering caused by terrorist attacks
October 20, 2018 - Eradicating Helicobacter pylori infections may be a key treatment for Parkinson’s disease
October 20, 2018 - Breast Cancer as a Dynamic Disease
October 20, 2018 - University of Pittsburgh wins NSF grant for big data research to prevent complications from anesthesia
October 20, 2018 - Skin-to-skin contact may promote attachment between parents and preterm infants
October 20, 2018 - Recommendations Developed to Verify NGT Placement in Children
October 20, 2018 - Weight loss can be boosted fivefold thanks to novel mental imagery technique
October 20, 2018 - Children with autism are more likely to be overweight, obese
October 20, 2018 - Nurses making conscientious objections to ethically-relevant policies lack support
October 20, 2018 - Prion strain diversity may be greater than previously thought
October 20, 2018 - Antidepressant treatment may lead to improvements in sleep quality of patients with depression
October 20, 2018 - Study reports increased risk of death in children with inflammatory bowel disease
October 20, 2018 - Number of Autism Genes Now Tops 100
October 20, 2018 - Total diet replacement programmes are effective for treating obesity
October 20, 2018 - CLARIOstar used for fluorescence measurements on CSIRO’s purpose-built research vessel
October 20, 2018 - People with more copies of AMY1 gene digest starchy carbohydrates faster
October 20, 2018 - Case Comprehensive Cancer Center wins NIH grant to study health disparities
October 20, 2018 - Newly discovered compound shows potential for treating Parkinson’s disease
October 20, 2018 - High rate of non-adherence to hormonal therapy found among premenopausal early breast cancer patients
October 20, 2018 - Immunotherapy medicine found to be effective in treating uveitis
October 20, 2018 - The Pistoia Alliance Calls for Greater Collaboration to Realise Benefits of Innovation and Announces Winners of the 2018 President’s Startup Challenge
October 20, 2018 - Female internists consistently earn less than men
October 20, 2018 - Stanford team looks at dangers of teens’ vaping habits
October 20, 2018 - New approach to understanding cancers will accelerate development of better treatments
October 20, 2018 - LJI and UC San Diego awarded $ 4.5 million as part of NCI’s Cancer Moonshot initiative
October 20, 2018 - School-based HPV vaccination did not increase risky sexual behaviors among adolescent girls
October 20, 2018 - Eye discovery to pave way for more successful corneal transplants
October 20, 2018 - New analysis examines the importance of location in the opioid crisis
October 20, 2018 - Green filters increase reading speed for children with dyslexia
October 19, 2018 - Bariatric Sx Cuts Macrovascular Complications in Obesity, T2DM
October 19, 2018 - Better assessments for early age-related macular degeneration
October 19, 2018 - Visible and valued: Stanford Medicine’s first-ever LGBTQ+ Forum | News Center
October 19, 2018 - Understanding of metal-free enzymes used by bacteria could lead to new effective antibiotics
October 19, 2018 - Beckman Coulter Life Sciences announces new research-focused website
October 19, 2018 - Study finds link between refined soluble fibers, gut microbiota and liver cancer
October 19, 2018 - Social media reduces risk of depression among seniors with pain
October 19, 2018 - Newly developed synthetic DNA molecule may one day be used as ‘vaccine’ for prostate cancer
October 19, 2018 - Preoperative weight loss may not provide health benefits after surgery
October 19, 2018 - U.S. Birth Rates Continue to Drop as Age of New Moms Rises
October 19, 2018 - New technology can keep an eye on babies’ movements in the womb
October 19, 2018 - Juul e-cigarettes pose addiction risk for young users | News Center
October 19, 2018 - Gene sequencing reveals crucial molecular aspects of Trypanosoma brucei
October 19, 2018 - New DNA vaccine strategy protects mice against lethal challenge by multiple H3N2 viruses
October 19, 2018 - Study shows close link between cytokine interleukin-1ß and obesity-promoted colon cancer
October 19, 2018 - Muscle mass plays a critical role in health, shows research
October 19, 2018 - Study finds undiagnosed prediabetes in many infertile men
October 19, 2018 - The Current issue of “The view from here” is concerned with Nanotherapeutic strategies
October 19, 2018 - Delay in replacing the Pap smear with HPV screening is costing lives
October 19, 2018 - Physicians battle pediatric diseases of ear, nose, throat in Zimbabwe | News Center
October 19, 2018 - Researchers investigate why some cancers affect only young women
October 19, 2018 - Drugmakers funnel millions to lawmakers; a few dozen get $100,000-plus
October 19, 2018 - Unselfish people tend to have more children and receive higher salaries
October 19, 2018 - New findings reveal potential cellular players in tumor microenvironment
October 19, 2018 - Study reveals impact of Juul use on teenagers and young adults
October 19, 2018 - Green leafy vegetables could help reduce macular degeneration risk
October 19, 2018 - Some countries take more time for reimbursement decisions on new cancer drugs
October 19, 2018 - Human brain cell transplant offers insights into neurological conditions
October 19, 2018 - Parental education associated with increased family health care spending
October 19, 2018 - New statistical method estimates long- and short-term risk of recurrence of breast cancer in US women
October 19, 2018 - Father’s exposure to nicotine may cause cognitive deficits in descendants
October 19, 2018 - Could we prevent Alzheimer’s disease by treating herpes?
October 19, 2018 - Nurse-led care can be more successful in managing gout
October 19, 2018 - Trump administration, pharma exchange verbal volleys on drug-price transparency
Newly developed drug compound may help treat Charcot-Marie-Tooth disease

Newly developed drug compound may help treat Charcot-Marie-Tooth disease

image_pdfDownload PDFimage_print

Scientists have developed a new drug compound that shows promise as a future treatment for Charcot-Marie-Tooth disease, an inherited, often painful neurodegenerative condition that affects nerves in the hands, arms, feet and legs. The researchers used the compound to treat the nerves of mice harboring the genetic defects that cause the disease.

The new study, from Washington University School of Medicine in St. Louis, challenges some conventional wisdom regarding how patients with this disease lose the ability to move their limbs.

The study appears April 20 in the journal Science.

Charcot-Marie-Tooth is the most common inherited degenerative disease of peripheral nerves. The disease affects about one in 2,500 individuals worldwide, and there are no treatments for it. The researchers studied a form of the condition called Charcot-Marie-Tooth disease type 2A, which is caused by specific genetic mutations.

These patients have inherited mutations that affect mitochondria, the energy factories of cells. Healthy mitochondria fuse together and exchange mitochondrial DNA. This healthy mitochondrial “sex” is impaired in this disease because of mutations in a protein called mitofusin2, which governs mitochondrial fusion.

Because they can’t fuse, the mitochondria of people with this disease appear small, granular and clumped when viewed under a microscope. Until now, the small size was thought to be the main problem in the disorder. Small energy factories can’t produce enough fuel to keep nerves alive, so the cells slowly die off, the thinking went. But senior author Gerald W. Dorn II, MD, the Philip and Sima K. Needleman Professor of Medicine, suspected something else was going on.

Dorn knew the genetic mutations in this disease aren’t confined to nerves; rather, they are present in all of the mitochondria in every cell of the body. Nerve cells and, for example, heart muscle cells burn energy at high rates and need healthy, robust mitochondria for fuel. A cardiologist by training, Dorn wondered why patients with the disease don’t have heart problems.

“This disease starts with nerve loss in the feet, moves up the legs, then to the arms, but it doesn’t have major effects elsewhere,” said Dorn, also director of the School of Medicine’s Center for Pharmacogenomics. “People with Charcot-Marie-Tooth eventually may need wheelchairs, but they have normal lifespans.

“We found that the problem isn’t mitochondria that are too small, but mitochondria that can’t travel distances. In heart cells, mitochondria are packed like sardines and don’t need to move much, so there’s no problem with energy supply,” he said. “But for mitochondria to make it down a person’s leg -; following the sciatic nerve from the lumbar spine to the foot -; that’s akin to a 500-mile trip. If a person can’t constantly renew mitochondria, over the years the nerves start to atrophy. Once the nerves die, the muscles atrophy as well.”

With distance identified as a key factor, the ideal animal model to study this disease, Dorn quipped, is the giraffe. But since that’s not an option and mice don’t develop symptomatic Charcot-Marie-Tooth (because mice are small and their mitochondria don’t have far to go), Dorn and his colleagues extracted sciatic nerves -; the longest nerve in the body -; from mice and set up a way to compare the speeds of mitochondria moving up and down the nerves.

Co-first author Antonietta Franco, PhD, a postdoctoral researcher, found that mitochondria in the mouse nerves with Charcot-Marie-Tooth type 2A mutations were almost static, moving very little in the time frame observed, even when sped up with time-lapse photography. In contrast, mitochondria moving along the nerve axons of normal mice, viewed under the same time-lapse conditions, resembled an aerial shot of a highway.

The researchers then added a drug compound to the nerves with the static mitochondria. This drug, which they designed, works something like a chemical key that unlocks mitofusin2 and boosts mitochondrial fusion. The work developing the drug compound was led by co-first author Agostinho G. Rocha, PhD, a staff scientist.

“After about 15 minutes of exposure to the compound, the mitochondrial traffic began to pick up,” Dorn said. “And after an hour, it looked like the normal nerve. We also found that the drug doesn’t have an effect when added to normal nerves. Mitochondria appear to have a speed limit.”

While the researchers know this drug boosts the ability of diseased mitochondria to fuse to one another, Dorn said it’s possible this is not what lets them move. It may be that the unlocked form of mitofusin2 also lets mitochondria couple to what Dorn calls the railroad tracks of cells. But more research is needed to answer that question.

Dorn said these findings may be relevant for other neurodegenerative disorders in which mitochondria are impaired, including other types of Charcot-Marie-Tooth disease.

Source:

Defect in debilitating neurodegenerative disease reversed in mouse nerves

Tagged with:

About author

Related Articles